Study: Trastuzumab (Herceptin) Raises Risk of Heart Failure Cancer Network According to a large population-based, retrospective study of 12,500 women treated for invasive breast cancer, treatment with trastuzumab (Herceptin) increases the risk of congestive heart failure and cardiomyopathy. The research aimed to confirm the ... |
